ResearcherNational Institutes of HealthActive in the last 2 years
Paloma Moreno
Matched on OpenAlex author ID A5109801209. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2023: 1 paper · 2024: 3 papers · 2025: none · 2026: 1 paper
Papers 5
- Molecular, metabolic, and histological subtypes of pancreatic ductal adenocarcinoma and its tumor microenvironment: Insights into tumor heterogeneity and clini… Co-author DOI 10.1016/j.pharmthera.2025.108946↗
- ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer. Co-author DOI 10.1002/ijc.34960↗
- LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism. Co-author DOI 10.1093/carcin/bgae011↗
- ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer. Co-author DOI 10.1093/carcin/bgae056↗
- SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer. Co-author DOI 10.1016/j.celrep.2023.113434↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuuki Ohara · 5 shared papers, 2023–2026 · strength 1.10
- Paper Molecular, metabolic, and histological subtypes of pancreatic ductal adenocarcinoma and its tumor microenvironment: Ins… DOI 10.1016/j.pharmthera.2025.108946↗
- Paper ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic re… DOI 10.1002/ijc.34960↗
- Paper LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through… DOI 10.1093/carcin/bgae011↗
- S. Perwez Hussain · 5 shared papers, 2023–2026 · strength 1.10
- Paper Molecular, metabolic, and histological subtypes of pancreatic ductal adenocarcinoma and its tumor microenvironment: Ins… DOI 10.1016/j.pharmthera.2025.108946↗
- Paper ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic re… DOI 10.1002/ijc.34960↗
- Paper LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through… DOI 10.1093/carcin/bgae011↗
- Nader N Hanna · 4 shared papers, 2023–2024 · strength 0.72
- Paper ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic re… DOI 10.1002/ijc.34960↗
- Paper LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through… DOI 10.1093/carcin/bgae011↗
- Paper ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer. DOI 10.1093/carcin/bgae056↗
- Michael B. Ghadimi · 4 shared papers, 2023–2024 · strength 0.72
- Paper ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic re… DOI 10.1002/ijc.34960↗
- Paper LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through… DOI 10.1093/carcin/bgae011↗
- Paper ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer. DOI 10.1093/carcin/bgae056↗
- Jochen Gaedcke · 4 shared papers, 2023–2024 · strength 0.72
- Paper ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic re… DOI 10.1002/ijc.34960↗
- Paper LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through… DOI 10.1093/carcin/bgae011↗
- Paper ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer. DOI 10.1093/carcin/bgae056↗
- Azadeh Azizian · 4 shared papers, 2023–2024 · strength 0.72
- Paper ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic re… DOI 10.1002/ijc.34960↗
- Paper LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through… DOI 10.1093/carcin/bgae011↗
- Paper ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer. DOI 10.1093/carcin/bgae056↗
- S. S. Yang · 2 shared papers, 2024 · strength 0.37
- Shouhui Yang · 2 shared papers, 2023–2024 · strength 0.34
- Paper ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic re… DOI 10.1002/ijc.34960↗
- Paper SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer. DOI 10.1016/j.celrep.2023.113434↗
- Lin Zhang · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.